 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
apoptosis
|
2 terms
|
 |
|
Biochemical function
|
cysteine-type peptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
107:399-407
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding.
|
|
J.Chai,
Q.Wu,
E.Shiozaki,
S.M.Srinivasula,
E.S.Alnemri,
Y.Shi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Apoptosis is primarily executed by active caspases, which are derived from the
inactive procaspase zymogens through proteolytic cleavage. Here we report the
crystal structures of a caspase zymogen, procaspase-7, and an active caspase-7
without any bound inhibitors. Compared to the inhibitor-bound caspase-7,
procaspase-7 zymogen exhibits significant structural differences surrounding the
catalytic cleft, which precludes the formation of a productive conformation.
Proteolytic cleavage between the large and small subunits allows rearrangement
of essential loops in the active site, priming active caspase-7 for
inhibitor/substrate binding. Strikingly, binding by inhibitors causes a 180
degrees flipping of the N terminus in the small subunit, which interacts with
and stabilizes the catalytic cleft. These analyses reveal the structural
mechanisms of caspase activation and demonstrate that the inhibitor/substrate
binding is a process of induced fit.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A Structural Mechanism for the Activation of
Procaspase-7(A) Stabilization of the catalytic cleft by the
loop-bundle in the active caspase-7 bound with an XIAP fragment
(PDB code 1I51). The loop-bundle is nucleated by the free N
terminus (L2′) of the small subunit. These interactions occur
between two adjacent caspase-7 heterodimers. Fragments from
these two heterodimers are colored green and blue, respectively.
Their side chains are colored gold and yellow, respectively.
Hydrogen bonds are represented by red dashed lines.(B) The
uncleaved interdomain loop in the procaspase-7 zymogen is
restrained to adopt a different set of interactions. Fragments
from two adjacent heterodimers are colored gray and brown,
respectively.(C) Superposition of the loop-bundle in the active
caspase-7 and the corresponding regions in the procaspase-7
zymogen. Coloring scheme is the same as in (A) and (B). The
orientation of active caspase-7 is the same for (A) and (C). The
orientation of procaspase-7 in this panel is highly similar (a
rotation of 5° along vertical axis) to that in (B).(D)
Sequence alignment of the L2 loop region for caspase-3, -6, -7,
and -9. The catalytic Cys is highlighted in red, while conserved
residues are colored yellow. Interactions in the procaspase-7
zymogen and the XIAP-bound active caspase-7 are shown below and
above the alignment, respectively. Residues that make hydrogen
bonds in the loop-bundle region with their side chain and main
chain groups are indicated by red arrows and red squares,
respectively. Residues that make van der Waals contacts are
identified by blue squares. The scissors indicate the position
of activation cleavage in procaspase-7 and -3
|
 |
Figure 5.
Figure 5. Schematic Diagram of Caspase Activation and
Substrate/Inhibitor BindingThe active site loops in procaspase-7
zymogen are in an unproductive conformation for catalysis. The
contiguous interdomain loop in the procaspase-7 zymogen locks
the interdomain loop in a closed conformation and precludes a
conformational change that must accompany substrate/inhibitor
binding. The proteolytic cleavage after Asp198 rearranges the
active site loops and produces a free N terminus in the small
subunit (L2′). These changes ready the active caspase-7 for
substrate/inhibitor binding, which further induces a drastic
conformational switch
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(2001,
107,
399-407)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Shen,
P.J.Lupardus,
M.M.Gersch,
A.W.Puri,
V.E.Albrow,
K.C.Garcia,
and
M.Bogyo
(2011).
Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.
|
| |
Nat Struct Mol Biol, 18,
364-371.
|
 |
|
|
|
|
 |
D.Boucher,
V.Blais,
M.Drag,
and
J.B.Denault
(2011).
Molecular determinants involved in activation of caspase 7.
|
| |
Biosci Rep, 31,
283-294.
|
 |
|
|
|
|
 |
A.O.Amer
(2010).
Modulation of caspases and their non-apoptotic functions by Legionella pneumophila.
|
| |
Cell Microbiol, 12,
140-147.
|
 |
|
|
|
|
 |
J.A.Zorn,
and
J.A.Wells
(2010).
Turning enzymes ON with small molecules.
|
| |
Nat Chem Biol, 6,
179-188.
|
 |
|
|
|
|
 |
M.Lamkanfi,
and
T.D.Kanneganti
(2010).
Caspase-7: a protease involved in apoptosis and inflammation.
|
| |
Int J Biochem Cell Biol, 42,
21-24.
|
 |
|
|
|
|
 |
N.Keller,
M.G.Grütter,
and
O.Zerbe
(2010).
Studies of the molecular mechanism of caspase-8 activation by solution NMR.
|
| |
Cell Death Differ, 17,
710-718.
|
 |
|
|
|
|
 |
R.S.Whelan,
V.Kaplinskiy,
and
R.N.Kitsis
(2010).
Cell death in the pathogenesis of heart disease: mechanisms and significance.
|
| |
Annu Rev Physiol, 72,
19-44.
|
 |
|
|
|
|
 |
X.J.Wang,
Q.Cao,
X.Liu,
K.T.Wang,
W.Mi,
Y.Zhang,
L.F.Li,
A.C.LeBlanc,
and
X.D.Su
(2010).
Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation.
|
| |
EMBO Rep, 11,
841-847.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Pop,
and
G.S.Salvesen
(2009).
Human caspases: activation, specificity, and regulation.
|
| |
J Biol Chem, 284,
21777-21781.
|
 |
|
|
|
|
 |
J.A.Hardy,
and
J.A.Wells
(2009).
Dissecting an allosteric switch in caspase-7 using chemical and mutational probes.
|
| |
J Biol Chem, 284,
26063-26069.
|
 |
|
|
|
|
 |
J.Agniswamy,
B.Fang,
and
I.T.Weber
(2009).
Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.
|
| |
Apoptosis, 14,
1135-1144.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Gafni,
X.Cong,
S.F.Chen,
B.W.Gibson,
and
L.M.Ellerby
(2009).
Calpain-1 cleaves and activates caspase-7.
|
| |
J Biol Chem, 284,
25441-25449.
|
 |
|
|
|
|
 |
J.M.Elliott,
L.Rouge,
C.Wiesmann,
and
J.M.Scheer
(2009).
Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation.
|
| |
J Biol Chem, 284,
6546-6553.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.W.Yu,
P.D.Jeffrey,
and
Y.Shi
(2009).
Mechanism of procaspase-8 activation by c-FLIPL.
|
| |
Proc Natl Acad Sci U S A, 106,
8169-8174.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Walters,
C.Pop,
F.L.Scott,
M.Drag,
P.Swartz,
C.Mattos,
G.S.Salvesen,
and
A.C.Clark
(2009).
A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis.
|
| |
Biochem J, 424,
335-345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.J.Wee,
J.C.Tong,
T.W.Tan,
and
S.Ranganathan
(2009).
A multi-factor model for caspase degradome prediction.
|
| |
BMC Genomics, 10,
S6.
|
 |
|
|
|
|
 |
N.Keller,
J.Mares,
O.Zerbe,
and
M.G.Grütter
(2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
|
| |
Structure, 17,
438-448.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Baumgartner,
G.Meder,
C.Briand,
A.Decock,
A.D'arcy,
U.Hassiepen,
R.Morse,
and
M.Renatus
(2009).
The crystal structure of caspase-6, a selective effector of axonal degeneration.
|
| |
Biochem J, 423,
429-439.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.L.Milam,
and
A.C.Clark
(2009).
Folding and assembly kinetics of procaspase-3.
|
| |
Protein Sci, 18,
2500-2517.
|
 |
|
|
|
|
 |
W.A.Witkowski,
and
J.A.Hardy
(2009).
L2' loop is critical for caspase-7 active site formation.
|
| |
Protein Sci, 18,
1459-1468.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.J.Kang,
Y.M.Lee,
Y.J.Jeong,
K.Park,
M.Jang,
S.G.Park,
K.H.Bae,
M.Kim,
and
S.J.Chung
(2008).
Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors.
|
| |
BMC Biotechnol, 8,
92.
|
 |
|
|
|
|
 |
M.Lamkanfi,
T.D.Kanneganti,
P.Van Damme,
T.Vanden Berghe,
I.Vanoverberghe,
J.Vandekerckhove,
P.Vandenabeele,
K.Gevaert,
and
G.Núñez
(2008).
Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes.
|
| |
Mol Cell Proteomics, 7,
2350-2363.
|
 |
|
|
|
|
 |
D.A.Mitchell,
S.U.Morton,
N.B.Fernhoff,
and
M.A.Marletta
(2007).
Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells.
|
| |
Proc Natl Acad Sci U S A, 104,
11609-11614.
|
 |
|
|
|
|
 |
J.C.Timmer,
and
G.S.Salvesen
(2007).
Caspase substrates.
|
| |
Cell Death Differ, 14,
66-72.
|
 |
|
|
|
|
 |
Q.Bao,
and
Y.Shi
(2007).
Apoptosome: a platform for the activation of initiator caspases.
|
| |
Cell Death Differ, 14,
56-65.
|
 |
|
|
|
|
 |
D.Twiddy,
G.M.Cohen,
M.Macfarlane,
and
K.Cain
(2006).
Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAP-caspase-7 approximately 200-kDa complex.
|
| |
J Biol Chem, 281,
3876-3888.
|
 |
|
|
|
|
 |
J.Dobó,
R.Swanson,
G.S.Salvesen,
S.T.Olson,
and
P.G.Gettins
(2006).
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer.
|
| |
J Biol Chem, 281,
38781-38790.
|
 |
|
|
|
|
 |
N.Yan,
J.R.Huh,
V.Schirf,
B.Demeler,
B.A.Hay,
and
Y.Shi
(2006).
Structure and activation mechanism of the Drosophila initiator caspase Dronc.
|
| |
J Biol Chem, 281,
8667-8674.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.Liu,
and
N.Chejanovsky
(2006).
Activation pathways and signal-mediated upregulation of the insect Spodoptera frugiperda caspase-1.
|
| |
Apoptosis, 11,
487-496.
|
 |
|
|
|
|
 |
Q.Yin,
H.H.Park,
J.Y.Chung,
S.C.Lin,
Y.C.Lo,
L.S.da Graca,
X.Jiang,
and
H.Wu
(2006).
Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine.
|
| |
Mol Cell, 22,
259-268.
|
 |
|
|
|
|
 |
H.Liu,
D.W.Chang,
and
X.Yang
(2005).
Interdimer processing and linearity of procaspase-3 activation. A unifying mechanism for the activation of initiator and effector caspases.
|
| |
J Biol Chem, 280,
11578-11582.
|
 |
|
|
|
|
 |
K.Bose,
and
A.C.Clark
(2005).
pH effects on the stability and dimerization of procaspase-3.
|
| |
Protein Sci, 14,
24-36.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol, 21,
35-56.
|
 |
|
|
|
|
 |
S.Kamada,
U.Kikkawa,
Y.Tsujimoto,
and
T.Hunter
(2005).
A-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active caspase 3 through an enzyme-substrate-like association.
|
| |
Mol Cell Biol, 25,
9469-9477.
|
 |
|
|
|
|
 |
S.Piana,
Z.Taylor,
and
U.Rothlisberger
(2005).
Folding pathways for initiator and effector procaspases from computer simulations.
|
| |
Proteins, 59,
765-772.
|
 |
|
|
|
|
 |
Y.Chao,
E.N.Shiozaki,
S.M.Srinivasula,
D.J.Rigotti,
R.Fairman,
and
Y.Shi
(2005).
Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation.
|
| |
PLoS Biol, 3,
e183.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Ke,
K.Zhou,
F.Ding,
J.H.Cate,
and
J.A.Doudna
(2004).
A conformational switch controls hepatitis delta virus ribozyme catalysis.
|
| |
Nature, 429,
201-205.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.M.Forsyth,
D.Lemongello,
D.J.LaCount,
P.D.Friesen,
and
A.J.Fisher
(2004).
Crystal structure of an invertebrate caspase.
|
| |
J Biol Chem, 279,
7001-7008.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Vercammen,
B.van de Cotte,
G.De Jaeger,
D.Eeckhout,
P.Casteels,
K.Vandepoele,
I.Vandenberghe,
J.Van Beeumen,
D.Inzé,
and
F.Van Breusegem
(2004).
Type II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine.
|
| |
J Biol Chem, 279,
45329-45336.
|
 |
|
|
|
|
 |
J.A.Hardy,
J.Lam,
J.T.Nguyen,
T.O'Brien,
and
J.A.Wells
(2004).
Discovery of an allosteric site in the caspases.
|
| |
Proc Natl Acad Sci U S A, 101,
12461-12466.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Feng,
D.A.Gell,
S.Zhou,
L.Gu,
Y.Kong,
J.Li,
M.Hu,
N.Yan,
C.Lee,
A.M.Rich,
R.S.Armstrong,
P.A.Lay,
A.J.Gow,
M.J.Weiss,
J.P.Mackay,
and
Y.Shi
(2004).
Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin.
|
| |
Cell, 119,
629-640.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Alvarado-Kristensson,
F.Melander,
K.Leandersson,
L.Rönnstrand,
C.Wernstedt,
and
T.Andersson
(2004).
p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils.
|
| |
J Exp Med, 199,
449-458.
|
 |
|
|
|
|
 |
M.J.Romanowski,
J.M.Scheer,
T.O'Brien,
and
R.S.McDowell
(2004).
Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding.
|
| |
Structure, 12,
1361-1371.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Yan,
J.W.Wu,
J.Chai,
W.Li,
and
Y.Shi
(2004).
Molecular mechanisms of DrICE inhibition by DIAP1 and removal of inhibition by Reaper, Hid and Grim.
|
| |
Nat Struct Mol Biol, 11,
420-428.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Yan,
L.Gu,
D.Kokel,
J.Chai,
W.Li,
A.Han,
L.Chen,
D.Xue,
and
Y.Shi
(2004).
Structural, biochemical, and functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4.
|
| |
Mol Cell, 15,
999.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol, 5,
897-907.
|
 |
|
|
|
|
 |
S.Piana,
and
U.Rothlisberger
(2004).
Molecular dynamics simulations of structural changes during procaspase 3 activation.
|
| |
Proteins, 55,
932-941.
|
 |
|
|
|
|
 |
X.Jiang,
and
X.Wang
(2004).
Cytochrome C-mediated apoptosis.
|
| |
Annu Rev Biochem, 73,
87.
|
 |
|
|
|
|
 |
Y.Shi
(2004).
Caspase activation, inhibition, and reactivation: a mechanistic view.
|
| |
Protein Sci, 13,
1979-1987.
|
 |
|
|
|
|
 |
Y.Shi
(2004).
Caspase activation: revisiting the induced proximity model.
|
| |
Cell, 117,
855-858.
|
 |
|
|
|
|
 |
C.A.Ryan,
and
G.S.Salvesen
(2003).
Caspases and neuronal development.
|
| |
Biol Chem, 384,
855-861.
|
 |
|
|
|
|
 |
E.N.Shiozaki,
J.Chai,
D.J.Rigotti,
S.J.Riedl,
P.Li,
S.M.Srinivasula,
E.S.Alnemri,
R.Fairman,
and
Y.Shi
(2003).
Mechanism of XIAP-mediated inhibition of caspase-9.
|
| |
Mol Cell, 11,
519-527.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.B.Denault,
and
G.S.Salvesen
(2003).
Human caspase-7 activity and regulation by its N-terminal peptide.
|
| |
J Biol Chem, 278,
34042-34050.
|
 |
|
|
|
|
 |
J.Mikolajczyk,
K.M.Boatright,
H.R.Stennicke,
T.Nazif,
J.Potempa,
M.Bogyo,
and
G.S.Salvesen
(2003).
Sequential autolytic processing activates the zymogen of Arg-gingipain.
|
| |
J Biol Chem, 278,
10458-10464.
|
 |
|
|
|
|
 |
K.M.Boatright,
and
G.S.Salvesen
(2003).
Mechanisms of caspase activation.
|
| |
Curr Opin Cell Biol, 15,
725-731.
|
 |
|
|
|
|
 |
K.M.Boatright,
M.Renatus,
F.L.Scott,
S.Sperandio,
H.Shin,
I.M.Pedersen,
J.E.Ricci,
W.A.Edris,
D.P.Sutherlin,
D.R.Green,
and
G.S.Salvesen
(2003).
A unified model for apical caspase activation.
|
| |
Mol Cell, 11,
529-541.
|
 |
|
|
|
|
 |
M.Donepudi,
A.Mac Sweeney,
C.Briand,
and
M.G.Grütter
(2003).
Insights into the regulatory mechanism for caspase-8 activation.
|
| |
Mol Cell, 11,
543-549.
|
 |
|
|
|
|
 |
N.Holler,
A.Tardivel,
M.Kovacsovics-Bankowski,
S.Hertig,
O.Gaide,
F.Martinon,
A.Tinel,
D.Deperthes,
S.Calderara,
T.Schulthess,
J.Engel,
P.Schneider,
and
J.Tschopp
(2003).
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex.
|
| |
Mol Cell Biol, 23,
1428-1440.
|
 |
|
|
|
|
 |
S.R.Babu,
F.Bao,
C.M.Roberts,
A.K.Martin,
K.Gowan,
G.S.Eisenbarth,
and
P.R.Fain
(2003).
Caspase 7 is a positional candidate gene for IDDM 17 in a Bedouin Arab family.
|
| |
Ann N Y Acad Sci, 1005,
340-343.
|
 |
|
|
|
|
 |
C.M.Troy,
and
G.S.Salvesen
(2002).
Caspases on the brain.
|
| |
J Neurosci Res, 69,
145-150.
|
 |
|
|
|
|
 |
E.N.Shiozaki,
J.Chai,
and
Y.Shi
(2002).
Oligomerization and activation of caspase-9, induced by Apaf-1 CARD.
|
| |
Proc Natl Acad Sci U S A, 99,
4197-4202.
|
 |
|
|
|
|
 |
J.Salgado,
A.J.García-Sáez,
G.Malet,
I.Mingarro,
and
E.Pérez-Payá
(2002).
Peptides in apoptosis research.
|
| |
J Pept Sci, 8,
543-560.
|
 |
|
|
|
|
 |
M.Chen,
A.Orozco,
D.M.Spencer,
and
J.Wang
(2002).
Activation of initiator caspases through a stable dimeric intermediate.
|
| |
J Biol Chem, 277,
50761-50767.
|
 |
|
|
|
|
 |
O.Micheau,
M.Thome,
P.Schneider,
N.Holler,
J.Tschopp,
D.W.Nicholson,
C.Briand,
and
M.G.Grütter
(2002).
The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
|
| |
J Biol Chem, 277,
45162-45171.
|
 |
|
|
|
|
 |
S.Gil-Parrado,
A.Fernández-Montalván,
I.Assfalg-Machleidt,
O.Popp,
F.Bestvater,
A.Holloschi,
T.A.Knoch,
E.A.Auerswald,
K.Welsh,
J.C.Reed,
H.Fritz,
P.Fuentes-Prior,
E.Spiess,
G.S.Salvesen,
and
W.Machleidt
(2002).
Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members.
|
| |
J Biol Chem, 277,
27217-27226.
|
 |
|
|
|
|
 |
Y.Shi
(2002).
Mechanisms of caspase activation and inhibition during apoptosis.
|
| |
Mol Cell, 9,
459-470.
|
 |
|
|
|
|
 |
S.J.Riedl,
P.Fuentes-Prior,
M.Renatus,
N.Kairies,
S.Krapp,
R.Huber,
G.S.Salvesen,
and
W.Bode
(2001).
Structural basis for the activation of human procaspase-7.
|
| |
Proc Natl Acad Sci U S A, 98,
14790-14795.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|